REG - MyHealthChecked PLC - Comment on Share Price Movement

MyhealthcheckedAnnouncement

01/03/2021 10:05

RNS Number : 6817Q
  
MyHealthChecked PLC
  
01 March 2021
  
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED.  ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
 
("MyHealthChecked" or the "Company") 
 
Comment on Share Price movement
 
MyHealthChecked Plc (AIM: MHC), the personalised healthcare company, notes the increase in its share price this morning, and has become aware of speculation over the weekend that a significant potential contract is in the pipeline.
 
As previously notified on 29 December 2020, the Company's COVID-19 testing service has been added to the UK Government's approved COVID-19 private testing providers list for General Testing, and the Test to Release for International Travel scheme introduced on 15 December 2020.
 
Whilst the Company is engaged in commercial discussions with a number of parties for the supply of COVID-19 testing kits, no contracts have been signed to date, nor is there any certainty that any of these discussions will result in commercial agreement.
 
As required by the AIM Rules for Companies, the Company will make further notifications as required.
 



MyHealthChecked plc


www.myhealthchecked.com




Penny McCormick, Chief Executive Officer


via Walbrook PR




Maddy Kennedy, Chief Financial Officer


















SPARK Advisory Partners Limited (NOMAD)


Tel: +44 (0)20 3368 3550




Neil Baldwin 


















Oberon Capital Ltd (Broker)


Tel: +44 (0)203 179 5344




Mike Seabrook


mikeseabrook@oberoninvestments.com














Walbrook PR Ltd (Media & Investor Relations)


Tel: +44 (0)20 7933 8780 or concepta@walbrookpr.com




Paul McManus


Mob: +44(0)7980 541 893 



 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
SPMJBMLTMTAMMLB